Biotech Stocks Surge as Small-Cap Investors Embrace Risky Plays
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – July 16, 2025
The small-cap and biotech segments saw broad strength on July 16, with nearly every name in our coverage posting double-digit gains. Investor attention gravitated toward clinical-stage biotechs and highly liquid penny stocks, driving pronounced volume surges. Below is a summary of today’s notable performers.
Key Performance Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| QLGN | 2.20 | 3.90 | 25,782,051 | 77.39% |
| VCIG | 0.80 | 1.05 | 33,916,554 | 30.58% |
| SLNH | 0.40 | 0.5894 | 17,839,475 | 47.67% |
| DTST | 4.08 | 5.25 | 7,873,825 | 28.59% |
| CYCC | 5.81 | 7.95 | 2,128,691 | 36.88% |
| NUWE | 9.20 | 16.45 | 20,449,888 | 78.72% |
| GTI | 0.06 | 0.0933 | 150,675,999 | 51.65% |
| PEW | 7.93 | 13.80 | 5,556,677 | 73.98% |
| APM | 0.49 | 1.85 | 130,366,361 | 276.17% |
| TDTH | 0.47 | 0.8652 | 25,739,791 | 84.93% |
| YHC | 2.80 | 7.77 | 32,480,617 | 177.94% |
| SRM | 6.86 | 10.15 | 24,886,625 | 48.11% |
| OPEN | 1.12 | 1.50 | 196,879,357 | 33.63% |
| OP | 1.18 | 1.85 | 7,058,767 | 56.25% |
| HUBC | 2.87 | 4.20 | 1,831,507 | 46.33% |
| FTRK | 0.38 | 0.6544 | 9,813,277 | 70.18% |
| ARDT | 10.31 | 12.02 | 643,380 | 16.62% |
| GBIO | 0.43 | 0.57 | 8,104,511 | 34.07% |
Market Trends and Analysis
Today’s trading session was characterized by aggressive moves in speculative names, particularly within the biotechnology and digital-services spheres. Clinical-stage biotechs responded to trial updates and governance announcements:
- NUWE surged nearly 79% after revealing a strategic governance overhaul and renewed funding commitments for its fluid-management platform.
- QLGN climbed 77% on news of management appointments and progress in its oncology pipeline.
Penny stocks also dominated headlines as investors chased outsized returns:
- APM soared 276% on heavy volume following the termination of a proposed merger and indications of narrowing operating losses.
- GTI and TDTH more than doubled trading interest, posting gains of 52% and 85%, respectively, as both companies highlighted new partnership agreements.
High-liquidity issues like OPEN and YHC saw significant turnover, underscoring strong retail participation. OPEN traded nearly 197 million shares, lifting the price 33.6%, while YHC’s 178% rally reflected optimism around its recent marketing initiatives and stake acquisition in Canada.
Overall, the session reinforced a risk-on stance among small-cap investors, with volume surges outpacing price gains in many cases. The convergence of clinical news, restructuring updates, and speculative momentum drove today’s standout performances.
Biotech gains by CDC
Notable Movers
- APM (Aptorum Group Limited): +276.17%, 130M shares — major volume spike on merger news and compliance updates.
- YHC (LQR House Inc.): +177.94%, 32M shares — strategic marketing pushes and new brand acquisitions in Canada.
- TDTH (Trident Digital Tech): +84.93%, 25.7M shares — ADSs leapt after announcing government identity-verification projects.
- NUWE (Nuwellis Inc.): +78.72%, 20.4M shares — governance changes and R&D funding commitments for Aquadex innovations.
TL;DR
- Small-caps and biotechs led broad gains on July 16, 2025, with nearly all covered names up by double digits.
- APM topped the leaderboard, jumping 276% on merger termination and operational updates.
- NUWE and QLGN saw sizable biotech rallies amid governance shifts and pipeline progress.
- High-volume penny stocks (GTI, TDTH, OPEN) reflected a pronounced risk-on sentiment among retail investors.